StockData
Celularity Inc logo

Celularity Inc (CELU) income statement

CELUNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Oct 20, 2026Score 7/30
$0.47−0.02 (-3.15%)

Close on Nov 19, 2026Market cap $15.18MP/E –Yield –

See a number that looks wrong?